These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36397101)
1. Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis. Guo C; Sun Y; Zhai W; Yao X; Gong D; You B; Huang CP; Zheng J; Chang C Cell Biosci; 2022 Nov; 12(1):185. PubMed ID: 36397101 [TBL] [Abstract][Full Text] [Related]
2. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion. Yue D; Wang Y; Sun Y; Niu Y; Chang C Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702 [TBL] [Abstract][Full Text] [Related]
3. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype. Xiao Y; Sun Y; Liu G; Zhao J; Gao Y; Yeh S; Gong L; Chang C Cancer Lett; 2019 Mar; 444():175-187. PubMed ID: 30448543 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia. Zhai W; Sun Y; Jiang M; Wang M; Gasiewicz TA; Zheng J; Chang C Oncogene; 2016 Sep; 35(37):4866-80. PubMed ID: 26973243 [TBL] [Abstract][Full Text] [Related]
5. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis. Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087 [TBL] [Abstract][Full Text] [Related]
6. Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR. You B; Sun Y; Luo J; Wang K; Liu Q; Fang R; Liu B; Chou F; Wang R; Meng J; Huang CP; Yeh S; Chang C; Xu W Oncogene; 2021 Mar; 40(9):1674-1689. PubMed ID: 33510354 [TBL] [Abstract][Full Text] [Related]
7. CD4 + T cells promote renal cell carcinoma proliferation via modulating YBX1. Wang Y; Wang Y; Xu L; Lu X; Fu D; Su J; Geng H; Qin G; Chen R; Quan C; Niu Y; Yue D Exp Cell Res; 2018 Feb; 363(1):95-101. PubMed ID: 29289594 [TBL] [Abstract][Full Text] [Related]
8. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals. Song W; Li L; He D; Xie H; Chen J; Yeh CR; Chang LS; Yeh S; Chang C Cancer Lett; 2015 Nov; 368(1):71-78. PubMed ID: 26231735 [TBL] [Abstract][Full Text] [Related]
9. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression. Shi H; Sun Y; He M; Yang X; Hamada M; Fukunaga T; Zhang X; Chang C Oncogene; 2020 Jan; 39(3):530-545. PubMed ID: 31501521 [TBL] [Abstract][Full Text] [Related]
10. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals. Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling. Guan Z; Li C; Fan J; He D; Li L Sci Rep; 2016 Nov; 6():37085. PubMed ID: 27848972 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma. Adelaiye-Ogala R; Damayanti NP; Orillion AR; Arisa S; Chintala S; Titus MA; Kao C; Pili R Cancer Res; 2018 Jun; 78(11):2886-2896. PubMed ID: 29572225 [TBL] [Abstract][Full Text] [Related]
13. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth. Wang K; Sun Y; Guo C; Liu T; Fei X; Chang C Cell Death Dis; 2019 Apr; 10(5):339. PubMed ID: 31000693 [TBL] [Abstract][Full Text] [Related]
14. Intracrine androgen biosynthesis in renal cell carcinoma. Lee GT; Han CS; Kwon YS; Patel R; Modi PK; Kwon SJ; Faiena I; Patel N; Singer EA; Ahn HJ; Kim WJ; Kim IY Br J Cancer; 2017 Mar; 116(7):937-943. PubMed ID: 28253524 [TBL] [Abstract][Full Text] [Related]
15. YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2. Cui Q; Wang C; Liu S; Du R; Tian S; Chen R; Geng H; Subramanian S; Niu Y; Wang Y; Yue D Cell Cycle; 2021 Nov; 20(22):2413-2427. PubMed ID: 34709966 [TBL] [Abstract][Full Text] [Related]
16. Circ-SAR1A Promotes Renal Cell Carcinoma Progression Through miR-382/YBX1 Axis. Zhao X; Zhao Z; Xu W; Liu H; Chang J; Xu W; Li S; Cao S; Hou J Cancer Manag Res; 2020; 12():7353-7361. PubMed ID: 32884349 [TBL] [Abstract][Full Text] [Related]
17. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer. Kregel S; Kiriluk KJ; Rosen AM; Cai Y; Reyes EE; Otto KB; Tom W; Paner GP; Szmulewitz RZ; Vander Griend DJ PLoS One; 2013; 8(1):e53701. PubMed ID: 23326489 [TBL] [Abstract][Full Text] [Related]
18. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Li L; Dang Q; Xie H; Yang Z; He D; Liang L; Song W; Yeh S; Chang C Oncotarget; 2015 Jun; 6(16):14179-90. PubMed ID: 25895025 [TBL] [Abstract][Full Text] [Related]
19. Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling. He M; Yang H; Shi H; Hu Y; Chang C; Liu S; Yeh S Cancer Lett; 2022 Jan; 524():15-28. PubMed ID: 34461182 [TBL] [Abstract][Full Text] [Related]
20. Transcription factor Six2 induces a stem cell-like phenotype in renal cell carcinoma cells. Cheng N; Li H; Han Y; Sun S FEBS Open Bio; 2019 Oct; 9(10):1808-1816. PubMed ID: 31420918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]